June 21, 2022
ATLAS and the Weight of Experience
PHRI Senior Scientist Jeff Healey spoke at a webinar today about the results of his trial looking at S-ICD versus...
Read MoreJune 21, 2022
PHRI Senior Scientist Jeff Healey spoke at a webinar today about the results of his trial looking at S-ICD versus...
Read MoreJune 20, 2022
PHRI Investigators Marie Pigeyre and Matt Lanktree co-hosted the OMICS and Epidemiology conference last week, where presenters explored the challenges...
Read MoreJune 6, 2022
PHRI Deputy Director and Senior Scientist Hertzel Gerstein received the 2022 Outstanding Achievement in Clinical Diabetes Research Award, presented at...
Read MoreJune 1, 2022
Coming together in-person as an organization used to be a regular occurrence for PHRI: research days, lectureships, symposiums and rounds...
Read MoreMay 30, 2022
You know a vanguard study has been very successful when one of its key objectives – assessing recruitment potential – ...
Read MoreMay 25, 2022
PHRI’s COMPASS Long Term Open Label Extension (LTOLE) “further highlights and supports long-term use of [Factor Xa inhibitor anticoagulant] rivaroxaban,...
Read MoreMay 11, 2022
PHRI Investigator Aristeidis Katsanos, a member of our stroke and brain health research program, has been given a Young Investigator...
Read MoreMay 9, 2022
Three winners of the PHRI-based transdisciplinary research grant program in Hamilton, Canada (new this year) – called Transforming Tomorrow Today,...
Read MoreMay 3, 2022
PHRI is one of six hubs of research in the new Canadian Heart Function Alliance (CHF Alliance) network launched today...
Read MoreApril 30, 2022
ATLAS S-ICD RCT at PHRI led by Jeff Healey and Blandine Mondesert presented at Heart Rhythm 2022 found that S-ICD reduced lead-related complications for patients compared to TV-ICD.
Read MoreApril 22, 2022
At a recent PHRI townhall, we projected the image of a pair of Dutch wooden clogs as Janette Panhuis began...
Read MoreApril 4, 2022
PHRI Scientist Maura Marcucci presented today at ACC 2022 on the arm of the POISE-3 trial looking at blood pressure...
Read MoreApril 4, 2022
Banner image © ACC/Nick Agro 2022 Day 1 (April 2) at ACC 2022 was a big day for PHRI researchers....
Read MoreApril 3, 2022
The first clinical trial of the flu vaccine’s effectiveness in patients with heart failure (HF), IVVE, has found that flu...
Read MoreApril 3, 2022
PHRI Scientist Sanjit Jolly presented a session at ACC 2022 on the stent registry that is part of the CLEAR...
Read MoreBack To Top
Notifications